Micropulsed laser for swelling in inherited retina conditions
Part of Eyes & vision clinical trials.
This study tests whether a micropulsed laser can reduce swelling in the macula (central vision area) in people with inherited retinal diseases. It may help improve or stabilize vision-related swelling seen on detailed eye scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an inherited retinal (genetic) eye condition confirmed by genetic testing
- You are between 18 and 80 years old and can consent to the study
- Your eye scan shows macular swelling that does not improve enough after standard treatments (time limits apply)
- Your central retina thickness is above the study’s cutoffs (slightly different for men vs. women)
- You can attend all study visits and follow instructions (and can complete the required eye tasks)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial tests MS-553 to see how it works and how safely it can be given to people with diabetic retinopathy causing central macular swelling (macular edema). You may be considered if your vision and eye scan results match, and if you can follow frequent study visits.
This trial tests a gentle laser treatment (micropulse laser) to reduce swelling in the center of the retina caused by diabetes. The goal is to improve or protect your vision without the need for injections or stronger laser.
This trial tests a special laser treatment for diabetic macular edema, a swelling in the back of the eye caused by diabetes. It aims to see if the laser can help patients who have not improved with standard treatment.
This trial tests whether switching from anti-VEGF injections to a special laser is better than continuing injections alone for people with diabetic macular edema whose central retinal thickness has dropped below 400 microns after the first year of treatment.
This study tests a gentle laser treatment called micropulse laser for people with chronic central serous chorioretinopathy. It aims to help dry up the fluid under the retina that has not responded to standard medications for at least 6 months.
This trial studies a mild (“subthreshold”) laser treatment for reticular pseudodrusen (RPD) caused by age-related macular degeneration (AMD). If you qualify, the goal is to see whether the laser helps preserve or improve vision by targeting these specific eye changes.
Hear when a new Macular Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.